ICAD INC. - COMMON STO

iCAD Reports Financial Results for First Quarter Ended March 31, 2022

11 May 2022 15:07:23 By Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Clinical and IT Experts from Wake Radiology

28 Apr 2022 07:00:03 By Nasdaq GlobeNewswire

iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11

27 Apr 2022 07:00:02 By Nasdaq GlobeNewswire

iCAD Announces Significant Commercial Momentum for ProFound AI Among Customers Equipped with the Leading Provider of 3D Mammography Systems

26 Apr 2022 07:00:03 By Nasdaq GlobeNewswire

iCAD Announces Estimated Q1 Revenue and Upcoming Board and CFO Transitions

21 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

iCAD Launches ProFound Insights, ProFound Impact Webinar Series on April 27

19 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

iCAD Announces Additional Patients Treated Under GLIOX Trial and Continued Global Momentum for Xoft Intraoperative Radiation Therapy (IORT) for Brain, Rectal, Head and Neck Tumor Treatment

05 Apr 2022 07:00:02 By Nasdaq GlobeNewswire

iCAD Showcases Innovative Breast Health Solutions Platform at National Consortium of Breast Centers (NCoBC) 31st Annual Conference

10 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference

09 Mar 2022 10:21:38 By Nasdaq GlobeNewswire

iCAD Among the First to Validate its AI Cancer Detection Solutions with the NVIDIA AI Enterprise Software Suite

02 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

iCAD to Present at the 42nd Annual Cowen Health Care Conference

01 Mar 2022 07:00:03 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2021

28 Feb 2022 15:05:01 By Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

14 Feb 2022 15:05:00 By Nasdaq GlobeNewswire

iCAD to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

08 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

24 Jan 2022 13:25:38 By Nasdaq GlobeNewswire

iCAD Announces the Appointment of New Members to its Board of Directors

11 Jan 2022 07:00:01 By Nasdaq GlobeNewswire

iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues

04 Jan 2022 07:00:03 By Nasdaq GlobeNewswire

iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event

23 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States

14 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

06 Dec 2021 12:38:56 By Nasdaq GlobeNewswire